Professor Catherine Law
James Spence Medallist and Honorary Fellow
Professor Law is the Deputy Director (Strategy and Partnerships) at UCL Institute of Child Health. She is also Vice Dean for Research in the Faculty of Population Health Sciences. Her research interests are in child public health, particularly physical growth, inequalities in health, and the use of research for public policy. She was inaugural Chair of the Public Health Advisory Committee of NICE (2005-2015). From 2008-2014 she was inaugural Programme Director of the National Institute of Health Research’s (NIHR) Public Health Research Programme. She is Chair of the Medical Research Council Global Health Group and a member of MRC Strategy Board. She is also a member of the WHO Europe Advisory Committee on Health Research.
Professor Law has an active interest in the use and development of research for public policy. In addition to her research work, she was the scientific secretary of the Independent Inquiry into Inequalities in Health (1997-8), commissioned by the previous UK Government to inform its health policy, co-ordinated the Department of Health’s Research and Development Strategy for Public Health (2001), and collated the evidence base for the National Service Framework for Children and Young People (2004, Department of Health). She continues to work with the Department of Health and other policymaking organisations at the interface of research and policy.
She has been involved in the Public Health Consortium since 2005 in various roles and she was the Principal Investigator of three research project relating to public policy and its relation to child health.
Professor Law’s current research relates to obesity in children, particularly determining the contribution of fetal and early childhood growth to lifetime health, how public policy might influence current trends in childhood obesity, and how national and local interventions to prevent childhood obesity might be developed and evaluated, particularly in relation to disadvantaged groups.
Professor Law has been awarded the James Spence Medal for her scientific approach to inequalities in health and tireless work in promoting children’s health through a life course approach.
Professor Paul Colditz
Professor Colditz is the Director of the Perinatal Research Centre and Deputy Director at University of Queensland Centre for Clinical Research. More recently he has been appointed to the position of President-elect, Paediatrics and Child Health Division, Royal Australasian College of Physicians.
He is involved in the clinical care of babies and their families in the Neonatal Intensive Care Unit and in the clinical assessment of infant neurodevelopment.
Professor Colditz has professional qualifications in paediatrics, biomedical engineering and medical research. He is involved in teaching, clinical practice, taking care of babies and their families in the Neonatal Intensive Care Unit and in the clinical assessment of infant neurodevelopment.
His research group has become an international leader in the development of the preterm connectome using MRI.
Professor Colditz has an exceptional record of research, overseeing the growth of the internationally regarded Perinatal Research Centre. His work on neonatal seizures contributed towards the Queensland Clinical Guidelines on treatment of neonatal seizures. His research is key to the current ‘state of the art’ neonatal brain monitoring in NICUs throughout the world.
In 2013 Professor Colditz was awarded lifetime membership of ‘SIDS and Kids’ in Australia. This rare honour was in recognition of the many years he has dedicated to the national bereavement counselling organisation, for parents who have experienced the sudden or unexpected death of a baby or child.
Professor Sarah Creighton
Professor Sarah Creighton’s tireless and innovative work has led to increased recognition of the speciality of paediatric and adolescent gynaecology (PAG). She is the UK’s leading specialist in PAG and since her appointment as a consultant gynaecologist in 1995 she has achieved the important goal of developing PAG as a recognised subspecialty. As a result, all children and young people (CYP) seen by general and specialists paediatricians will benefit from the influence that speciality brings to their clinical practice.
Her contributions in the areas of normal paediatric genitalia and its variants, disorders of sex development (DSD), female genital mutilation (FGM) and in developing innovative surgical techniques for children with complex congenital anomalies have transformed the services and the standards of care provided locally, nationally and internationally. She has made major contributions to education for paediatricians including e-learning and a PAG textbook. Her training on FGM with a level 3 safeguarding course for paediatricians at the RCPCH was unique in the UK.
Her extensive research includes over 250 papers in peer reviewed papers, including the Archives of Diseases in Childhood and with paediatric colleagues. These have been important for the dissemination of her surgical techniques and understanding of very complex conditions in CYP. Her clinical practice has influenced paediatric colleagues and their understanding of, congenital abnormalities, endocrine conditions, female genital mutilation and female cosmetic genital surgery. Through national clinical guidance she has had a major impact upon gynaecological services for children and adolescents.
Since her appointment as consultant gynaecologist in 1995, Sarah has worked to develop appropriate health care for children and young people with gynaecological concerns. She was adamant that such children should not be managed in adult general gynaecology clinics. She established a dedicated PAG clinic with specialised nursing and psychology input. The clinic has grown into a well-regarded multidisciplinary in-patient and out-patient service. The service manages adolescent and adult patients with DSD/intersex and other complex genital anomalies.
In 1995 Sarah established a female only clinic for women with FGM offering medical and psychological support as well as including de-infibulation. However Sarah noted increasing numbers of referrals for adolescents with FGM at the same time as Dr Deborah Hodes was referred increasing numbers of young children with FGM. Close liaison between the two clinicians led to them setting up the world’s first dedicated multidisciplinary paediatric FGM service. This service is unique and offers medical and psychological support for children with FGM or suspected FGM.
She was a founder member and past Chair of the British Society for Paediatric and Adolescent Gynaecology (BritSPAG) (1999-current). She has improved the management of adolescents with complex genital anomalies, disseminating this when chair of NHS England CRG for Specialised Services for Women (2012-2019)
She is working to standardise clinical specialist services and is now chairing the NHS England working party for children with DSD/Intersex. She was a member of the Children’s Surgical Forum, at the Royal College of Surgeons (2002-2018)
Sarah is a leading expert on FGM in children and has been called to the Criminal Court as an expert witness including the recent successful prosecution.
Sarah’s main international achievement is her high quality clinically relevant research work and publications. Her published papers have changed PAG practice around the world.
As early in her career as 2009 she was the Stakeholder Representative on RCPCH Committee to write the evidence based handbook on The Physical Signs of Child Abuse. She has made a major contribution to the BPSU study on FGM as a member of the RCPCH BPSU FGM study group. There have been well received presentations on the study at the RCPCH annual conferences in 2018 and 2019.
Sarah has made a vital contribution to the work of the RCPCH as a founder member and past Chair of the British Society for Paediatric and Adolescent Gynaecology (BritSPAG) (1999-current). This society parallels the recognition in the College of the importance of understanding the particular needs of adolescents. Some of these ideas she has bought to the mainly adult trained gynaecologists. Sarah’s hard work has raised the profile of gynaecological conditions in children and adolescents in the College thereby contributing to the existing work that the RCPCH has implemented.
Dr Carol Ewing
Dr Carol Ewing worked as a Consultant Paediatrician at the Royal Manchester Children’s Hospital for 24 years. Her special interests are paediatric allergy/atopic eczema. From 2004 to 2012, she led on strategic workforce development for a large-scale reconfiguration of Greater Manchester’s children’s and maternity services. From 2013 to 2014, Dr Ewing was clinical lead for children’s services for Greater Manchester, Lancashire and South Cumbria Strategic Clinical Network (SCN), NHS England. She is currently a clinical adviser to Greater Manchester Strategic Clinical Network, and co-author of a city-wide child health and wellbeing strategy to ensure that children have the best start in life.
Dr Ewing has been involved in work towards driving up the standards of care and she was on the Project Board of Facing the Future 2017 Audit. Based on this vital document she was able to give recommendations on 3 key points: children seen by a consultant within 14 hours of admission, two consultant led hand overs and paediatric presence at peak times.
She was Vice President for Health Policy from 2014 to 5 March 2019. Following her term Workforce Planning Officer. In addition to advocating nationally to improve outcomes for children, she has helped to develop and implement quality standards and models of care to improve child health and services.
Dr Ewing has been a consultant paediatrician at the Royal Manchester Children’s Hospital (and previously at Booth Hall Children’s Hospital) since June 1993. She retired from clinical practice in 2019 but continues in her role as a Consultant Paediatrician to support her clinical lead duties. Dr Ewing is currently the RCPCH Ambassador for Greater Manchester. The Ambassador roles entails being an advocate for the integration and improvement of local services in ways that benefit children and young people, as described in the NHS Implementation Framework and being an advocate for the local paediatric workforce and broader child health workforce.
Professor Anne Greenough
Anne Greenough is Professor of Neonatology and Clinical Respiratory Physiology, Director of Education and Training at King’s Heath Partners Academic Health Science Centre. She was Board Member of the Higher Education Funding Council for England and Chair of the National Institute for Health Research (NIHR) Paediatrics (non medicines) Specialty Group.
Her example as a role model to generations of paediatric trainees is remarkable.
Professor Greenough’s research interests focus on the early origins of chronic respiratory disease and include factors affecting antenatal lung growth, optimisation of respiratory support, determinants of sudden infant death syndrome and prevention and treatment of chronic lung disease, particularly related to viral infections and sickle cell disease.
She has published hundreds of peer-reviewed papers, supervised nearly 30 doctoral theses, held prestigious research grants (gained in open competition) and made clinically important contributions to the recognition of those babies at risk of long term respiratory morbidity.
Professor Greenough was awarded the James Spence Medal (2017) for her outstanding career-long contribution to clinical and academic neonatology through work relating to the origins, markers and management of chronic lung disease following preterm birth
Professor Greenough was Vice President for Science and Research from 2014 until 5 March 2019. Throughout this time, she has maintained a role in clinical leadership, developing the highly regarded tertiary neonatal services at Kings College Hospital whilst retaining an interest in neonatal services in London.
Professor Alastair Hay
Professor Hay is a practising GP in Bristol, and Professor of Primary Care at the University of Bristol. He has provided clinical care to children and conducted research to improve the diagnosis and management of common infections in children, for over 20 years. With over 150 peer-reviewed original publications, H-index of 31, over £32M grants and over 15,000 children recruited to completed studies, he is widely regarded to be one of the UK’s strongest primary care paediatric researchers.
Scientific advances resulting from his research include: improved use of antibiotics - several papers (BMJ 2010, BMJ 2016, Annals of Fam Med 2016, and Lancet Resp Med 2016) have demonstrated the antimicrobial resistance effects of the indiscriminate routine use of antibiotics and provide algorithms to help clinicians target antibiotics to those most likely to benefit; antipyretics – his 2008 BMJ published RCT showed two antipyretics (paracetamol and ibuprofen) used alternately were superior to either antipyretic alone and at no additional cost; his BMJ 2013 paper describing the natural history of infection symptoms in children has informed Public Health England resources to help parents know when to seek medical help; and his topical analgesia for acute otitis media RCT (Health Tech Assess 2019) is the first UK primary care based demonstration that benzocaine reduces pain and reliance on antibiotics.
Together, his research represents a substantial contribution to evidence that is helping reduce the use of antibiotics, reduce distress to children and their families, and improve the use of hard-pressed NHS services.
He teaches on the world-renowned Bristol Medical School Short Courses in Population Health Sciences, teaching on the randomised controlled trials short course, and the clinical epidemiology MSc course, which attract participants from across the UK and around the world.
Professor Hay is a member of the NIHR Mentoring and Career Development Programme and since 2008 he has mentored two NIHR Clinical Lecturers, one NIHR SPRC Research Fellow, two NIHR SPCR doctoral fellows, two NIHR Launching Fellows and one NIHR Career Development Fellow.
Regionally, he has taught critical appraisal and research methods to over 500 Academic Fellows since 2002, initially as part of a MRCGP preparation course, but since 2010 as part of the University of Bristol’s Academic F2 Research Training Methods Teaching Programme.
He has supervised two PhDs in primary care paediatrics to completion, with both now holding post-doctoral research positions in his group.
Professor Hay qualified from the University of Sheffield in 1991 with a Distinction in Medicine. Initially training in adult medicine he achieved MRCP in 1995, and then completed a year of paediatric training at the Starship Hospital (Auckland) and DCH in 1997. He achieved MRCGP in 1997 and completed his MD (The Natural History of Acute Cough in Pre-School Children in Primary Care) at the University of Leicester in 2003. His national achievements have been recognised by the Royal College of GPs with the John Fry Award in 2001, FRCGP in 2012 and he was made a NIHR Senior Investigator in 2019. He continues to practise medicine at the CQC rated ‘outstanding’ Concord Medical Centre, Bristol.
He has received three nationally competitive research fellowships (NIHR Postdoctoral Fellowship (2004 to 2007), NIHR Career Development Fellowship (2010 to 2014), and NIHR Research Professor (2013 to 2018)); and three times his research has won the Royal College of GPs national ‘Research Paper of the Year’ award three times (2003, 2015 and 2016).
Nationally, he sits on the NICE Managing Common Infections Guideline Group, and has previously been a member of the 2009 NICE Gastroenteritis in Children Group. He chaired the 2015 NICE Antimicrobial Stewardship Guideline. Between 2013 and 2018, he was a member of the Government Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infections. Between 2013 and 2017 he was a member of the HTA Trials Board.
Professor Hay has contributed to the safety and quality of healthcare provided to children through his nationally and internationally recognised research, his contributions to national committees (NICE, HTA, UK government advisory committee, see above) and the high quality clinical care he provides (two clinical sessions per week), at a practice with a higher than average number of registered children.
Between 2006 and 2011, he was a scientific member of the Medicines for Children General Paediatrics Clinical Studies Group, helping the group prioritise research to be supported, and giving invited presentations to the National MCRN Directors’ Forum and the South West Medicines for Children Research Network.
Professor Hay is an ambassador for paediatric research in primary care. His multicentre research has provided a significant number of primary care studies to which over 15,000 children have been recruited since 2006 by dozens of CCGs, Acute Trusts and hundreds of GP practices across England and Wales.
Dr Lisa Kauffmann
Dr Kauffmann had worked for the University of Manchester since 1995 and her current roles are Consultant Community Paediatrician and Associate Medical Director for children’s community health services. She has a special interest in paediatric palliative care and has extensive experience in clinical governance, service development and medical performance management.
Her other passion is in supporting clinicians to improve their communications skills and she is a qualified communication skills trainer, delivering courses across the NHS and for the RCPCH.
Dr Kauffmann played a key role in the design and implementation of the ‘Making it Better’ project to redesign maternity and paediatric services. She has extensive experience in clinical governance, service development and medical performance management, and was the clinical governance lead for the Greater Manchester paediatric network.
Dr Kauffmann spent 4 years as Treasurer and chair of the Audit, Finance and Risk Committee. She had also chaired the RCPCH PiMM committee for many years and is currently the chair of BACCH.
She is involved in running the Royal College of Paediatrics clinical director’s training programme. She has reviewed community and acute paediatric services across the country and has advised the Welsh secretariat in their complaints process. Dr Kauffmann undertakes case investigations under MHPS and advises on clinical complaint investigations.
Dr Alison Tedstone
Dr Alison Tedstone is Chief Nutritionist and Deputy Director (Diet, Obesity and Physical Activity) at Public Health England – a post she has held since 2013. In this role, she has led PHE’s work on seeking calorie reduction and reformulation of food, with a particular focus on the impact of such reductions on children and young people. Before this, she was a Deputy Director at the Department of Health, responsible for national policy on nutrition and for nutrition legislation.
Dr Tedstone has authored a number of PHE reports related to her areas of responsibility, including Sugar reduction and wider reformulation programme: report on progress towards the first 5% reduction and next steps (2018), Calorie reduction: The scope and ambition for action (2018), and Sugar Reduction: Achieving the 20%. A technical report outlining progress to date, guidelines for industry, 2015 baseline levels in key foods and next steps (2017). In addition, she has authored or co-authored a number of peer-reviewed papers.
In her role at PHE, Dr Tedstone has been a strong supporter of the RCPCH’s work on nutrition and obesity, and a close collaborator with College officers and staff.